sleep / English

add

Learn how to keep your anxiety at bay and get a good night's sleep.

Eli Lilly noted that tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults that have both obstructive sleep apnea and obesity.

Eli Lilly's Zepbound showed promise to treat obstructive sleep apnea in two late-stage trials. It's yet another reason to stay invested in the drugmaker.

The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health issues and more in this weekly recap.

The car careered into a home in Chipperfield Road in Bromford injuring a 54-year-old man inside

Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday.

Eli Lilly's Zepbound doesn't just lead to weight loss, per the company. A 52-week study found a reduction in obstructive sleep apnea in adults with obesity, the company said Wednesday. Obstructive sleep apnea is a condition in which an…

The newest weight loss drug on the market, Zepbound, might also help keep people’s snoring down. On Wednesday, Eli Lilly announced the preliminary results of two Phase III trials testing its drug tirzepatide for people with both obesity…

The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea, according to new research. Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity drug tirzepatide — commonly known as Zepbound…

Spending too much time online to the point of compulsion and the neglect of other necessary activities, plus not sleeping or exercising enough, are linked to a heightened risk of both truancy and school absence due to illness among teens,…

Not getting enough sleep is a common affliction in the modern age. If you don't always get as many hours of shut-eye as you'd like, perhaps you were concerned by news of a recent study that found people who sleep less than six hours a…

Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials, drug maker Eli Lilly announced Wednesday.

Chude Jideonwo shares old video of Khloe declaring she can’t sleep with a married man for money following latest scandal Media personality and host of

"I'm adjacent!"

Zepbound reduced apnea effect by up to 63% and achieved about 20% weight loss after a year.

In two trials of people with sleep apnea, Zepbound reduced the number of times breathing slowed or stopped during sleep.

If you're into ambient noises and relaxation, you've come to the right place. Most people...

Based on results from trials in people with sleep apnea, the company said it plans to submit the material to the US Food and Drug Administration to potentially expand the use of Zepbound for obstructive sleep apnea.